{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:32:21Z","timestamp":1773685941872,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijmmb.2026.101079","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:21:31Z","timestamp":1771287691000},"page":"101079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Breakthrough invasive fungal infections during posaconazole prophylaxis in patients with hematologic malignancies at a tertiary care center - a 5-year audit from south India"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9161-8602","authenticated-orcid":false,"given":"P.K.","family":"Sowndharya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4629-1257","authenticated-orcid":false,"given":"Anjima","family":"Madhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8832-5955","authenticated-orcid":false,"given":"B.","family":"Gayathri Devi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5831-8250","authenticated-orcid":false,"given":"Farhana","family":"Basheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2838-3501","authenticated-orcid":false,"given":"Selin C.","family":"Joy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9654-2028","authenticated-orcid":false,"given":"Mazhuvancherry Kesavan","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5470-320X","authenticated-orcid":false,"given":"Rema","family":"Ganapathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijmmb.2026.101079_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/epirev\/mxae003","article-title":"A review of the epidemiology of invasive fungal infections in Asian patients with hematological malignancies (2011\u20132021)","volume":"46","author":"Iyadorai","year":"2024","journal-title":"Epidemiol Rev"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101079_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/jof8010033","article-title":"Epidemiology and antifungal susceptibility patterns of invasive fungal infections (IFIs) in India: a prospective observational study","volume":"8","author":"Dabas","year":"2022","journal-title":"J Fungi"},{"issue":"2","key":"10.1016\/j.ijmmb.2026.101079_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2016.09.002","article-title":"Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations","volume":"31","author":"Pagano","year":"2017","journal-title":"Blood Rev"},{"issue":"Suppl 2","key":"10.1016\/j.ijmmb.2026.101079_bib4","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ijmmb.2026.101079_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/myc.12960","article-title":"Defining breakthrough invasive fungal infection - position paper of the mycoses study Group Education and Research Consortium and the European Confederation of Medical Mycology","volume":"62","author":"Cornely","year":"2019","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101079_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cid\/ciae203","article-title":"Breakthrough invasive fungal infections in patients with high-risk hematological disorders receiving voriconazole and posaconazole prophylaxis: a systematic review","volume":"79","author":"Boutin","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ijmmb.2026.101079_bib7","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1111\/bcp.13707","article-title":"Co-administration of proton pump inhibitors and\/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies","volume":"84","author":"Cojutti","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101079_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ijmmb.2026.101079_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(20)30725-7","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Lehrnbecher","year":"2021","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101079_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ijmmb.2026.101079_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac603","article-title":"Burden of serious fungal infections in India","volume":"9","author":"Ray","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijmmb.2026.101079_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12281-016-0255-4","article-title":"Therapeutic drug monitoring of posaconazole: an update","volume":"10","author":"Dekkers","year":"2016","journal-title":"Curr Fungal Infect Rep"},{"issue":"10273","key":"10.1016\/j.ijmmb.2026.101079_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","article-title":"Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial","volume":"397","author":"Maertens","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ijmmb.2026.101079_bib13","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00432-017-2369-7","article-title":"Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation","volume":"143","author":"D\u00f6ring","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.ijmmb.2026.101079_bib15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3324\/haematol.2011.051995","article-title":"Comparative clinical effectiveness of prophylactic voriconazole\/posaconazole to fluconazole\/itraconazole in patients with acute myeloid leukemia\/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period","volume":"97","author":"Ananda-Rajah","year":"2012","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.ijmmb.2026.101079_bib16","doi-asserted-by":"crossref","first-page":"O952","DOI":"10.1111\/1469-0691.12688","article-title":"Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study","volume":"20","author":"Lerolle","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.ijmmb.2026.101079_bib17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/cam4.225","article-title":"Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study","volume":"3","author":"Kung","year":"2014","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101079_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jinf.2023.05.005","article-title":"Breakthrough invasive fungal infection among patients with haematologic malignancies: a national, prospective, and multicentre study","volume":"87","author":"Puerta-Alcalde","year":"2023","journal-title":"J Infect"},{"issue":"2","key":"10.1016\/j.ijmmb.2026.101079_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.15746\/sms.19.018","article-title":"Posaconazole versus itraconazole as prophylactic antifungal agents during induction chemotherapy for acute myeloid leukemia: a real-world single center comparison","volume":"25","author":"Kim","year":"2019","journal-title":"Soonchunhyang Med Sci"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101079_bib20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3324\/haematol.2011.053058","article-title":"Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience","volume":"97","author":"Girmenia","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.ijmmb.2026.101079_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/2040620720966882","article-title":"Efficacy of posaconazole prophylaxis in acute myeloid leukemia and myelodysplastic syndrome patients treated with hypomethylating agents","volume":"11","author":"Kang","year":"2020","journal-title":"Ther Adv Hematol"},{"issue":"9","key":"10.1016\/j.ijmmb.2026.101079_bib22","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1128\/AAC.00150-10","article-title":"Therapeutic drug monitoring of posaconazole in hematology patients: experience with a new high-performance liquid chromatography-based method","volume":"54","author":"Neubauer","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ijmmb.2026.101079_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myad046","article-title":"Breakthrough invasive fungal infection in patients with myeloid malignancy receiving posaconazole tablet prophylaxis: clinical features, risk factors, and posaconazole profiles","volume":"61","author":"Hong","year":"2023","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101079_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-46328-0","article-title":"Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia","volume":"13","author":"Tu","year":"2023","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ijmmb.2026.101079_bib25","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/cid\/ciy406","article-title":"Breakthrough fungal infections in patients with leukemia receiving isavuconazole","volume":"67","author":"Rausch","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101079_bib26","first-page":"277","article-title":"The outcome of antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: a single-center study","volume":"35","author":"\u00d6zkocaman","year":"2018","journal-title":"Turk J Haematol"},{"issue":"Pt 3","key":"10.1016\/j.ijmmb.2026.101079_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/0004563215618981","article-title":"Therapeutic drug monitoring of antimicrobials","volume":"53","author":"Balakrishnan","year":"2016","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101079_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf163","article-title":"Incidence of breakthrough fungal infections in patients with isavuconazole prophylaxis: a systematic review and meta-analysis","volume":"12","author":"Ishida","year":"2025","journal-title":"Open Forum Infect Dis"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S025508572600037X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S025508572600037X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:39:28Z","timestamp":1773682768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S025508572600037X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":28,"alternative-id":["S025508572600037X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101079","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breakthrough invasive fungal infections during posaconazole prophylaxis in patients with hematologic malignancies at a tertiary care center - a 5-year audit from south India","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101079"}}